BioCentury | Jun 6, 2005
Finance

Ebb & Flow

...joined International Biotechnology Trust as investment manager. Previously, he was the lead fund manager at Bioscience Investment Trust...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Sanders Morris Harris Group; PolyTechnos Venture-Partners; IBB Beteiligungsgesellschaft; bmp AG; NGN Capital; Life Sciences Partners; Bioscience Investment Trust...
BioCentury | Feb 21, 2005
Finance

Ebb & Flow

...total raised in the round. Investors in the second close included NGN; Life Sciences Partners; Bioscience Investment Trust...
BioCentury | Feb 14, 2005
Financial News

Jerini raises EUR 15.5M

...total raised in the round. Investors in the second close included NGN; Life Sciences Partners; Bioscience Investment Trust...
BioCentury | Jan 24, 2005
Finance

Tracking Epigenomics

...been buying, rather than selling, since the IPO in July 2004. Andy Smith of 3i Bioscience Investment Trust...
BioCentury | Jan 3, 2005
Finance

Value-driven in Europe

...sheer volume of financing activity in the U.S. According to Andy Smith, portfolio manager at Bioscience Investment Trust...
BioCentury | Dec 6, 2004
Finance

Ebb & Flow

...3i Bioscience Investment Trust. As part of the move, the fund will change its name to the Bioscience Investment Trust...
...Schroders takes over on Dec. 13, it will have two healthcare funds under management: the Bioscience Investment Trust...
...being part of the global healthcare team," said Andy Smith, who will continue to manage Bioscience Investment Trust...
BioCentury | Dec 21, 2000
Financial News

Oxagen nets 30 million

...disease-related genes, netted 30 million ($44.2 million) in private financing through Schroder Ventures; Abingworth; 3i Bioscience Investment Trust...
BioCentury | Dec 19, 2000
Financial News

Molecular Staging raises $41.3 million

...OrbiMed; CIBC Capital Partners; Cooper Hill Partners; Domain Partners III; CHL Medical Partners; and 3i Bioscience Investment Trust...
BioCentury | Aug 2, 2000
Financial News

Morphochem raises EUR40.7 million

...investors Techno Venture Management; Alta Partners; IKB Venture Capital; Alta Berkeley; Domain Associates; and 3i Bioscience Investment Trust...
Items per page:
1 - 10 of 13
BioCentury | Jun 6, 2005
Finance

Ebb & Flow

...joined International Biotechnology Trust as investment manager. Previously, he was the lead fund manager at Bioscience Investment Trust...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Sanders Morris Harris Group; PolyTechnos Venture-Partners; IBB Beteiligungsgesellschaft; bmp AG; NGN Capital; Life Sciences Partners; Bioscience Investment Trust...
BioCentury | Feb 21, 2005
Finance

Ebb & Flow

...total raised in the round. Investors in the second close included NGN; Life Sciences Partners; Bioscience Investment Trust...
BioCentury | Feb 14, 2005
Financial News

Jerini raises EUR 15.5M

...total raised in the round. Investors in the second close included NGN; Life Sciences Partners; Bioscience Investment Trust...
BioCentury | Jan 24, 2005
Finance

Tracking Epigenomics

...been buying, rather than selling, since the IPO in July 2004. Andy Smith of 3i Bioscience Investment Trust...
BioCentury | Jan 3, 2005
Finance

Value-driven in Europe

...sheer volume of financing activity in the U.S. According to Andy Smith, portfolio manager at Bioscience Investment Trust...
BioCentury | Dec 6, 2004
Finance

Ebb & Flow

...3i Bioscience Investment Trust. As part of the move, the fund will change its name to the Bioscience Investment Trust...
...Schroders takes over on Dec. 13, it will have two healthcare funds under management: the Bioscience Investment Trust...
...being part of the global healthcare team," said Andy Smith, who will continue to manage Bioscience Investment Trust...
BioCentury | Dec 21, 2000
Financial News

Oxagen nets 30 million

...disease-related genes, netted 30 million ($44.2 million) in private financing through Schroder Ventures; Abingworth; 3i Bioscience Investment Trust...
BioCentury | Dec 19, 2000
Financial News

Molecular Staging raises $41.3 million

...OrbiMed; CIBC Capital Partners; Cooper Hill Partners; Domain Partners III; CHL Medical Partners; and 3i Bioscience Investment Trust...
BioCentury | Aug 2, 2000
Financial News

Morphochem raises EUR40.7 million

...investors Techno Venture Management; Alta Partners; IKB Venture Capital; Alta Berkeley; Domain Associates; and 3i Bioscience Investment Trust...
Items per page:
1 - 10 of 13